Standard BioTools Inc (LAB)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$1.42
Buy
$1.45
$-0.03 (-2.03%)
Prices updated at 12 Dec 2025, 22:43 EST
| Prices minimum 15 mins delay
Prices in USD
Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 48.31 |
| 2023 | 47.44 |
| 2022 | 37.83 |
| 2021 | 53.13 |
| 2020 | 60.32 |
| 2019 | 54.83 |
| 2018 | 54.57 |
| 2017 | 50.99 |
| 2016 | 55.95 |
| 2015 | 59.35 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.24 |
| 2024 | 3.14 |
| 2023 | 1.66 |
| 2022 | 0.83 |
| 2021 | 2.15 |
| 2020 | 3.38 |
| 2019 | 1.77 |
| 2018 | 3.10 |
| 2017 | 1.81 |
| 2016 | 1.91 |
| 2015 | 2.63 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -39.53 |
| 2023 | -20.93 |
| 2022 | -57.13 |
| 2021 | -19.75 |
| 2020 | -17.99 |
| 2019 | -22.79 |
| 2018 | -19.97 |
| 2017 | -20.39 |
| 2016 | -22.47 |
| 2015 | -13.71 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.30 |
| 2023 | - |
| 2022 | - |
| 2021 | 2.91 |
| 2020 | 2.34 |
| 2019 | 1.72 |
| 2018 | 4.21 |
| 2017 | 9.29 |
| 2016 | 5.76 |
| 2015 | 3.22 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
